Doorgaan naar inhoud

Perioperatieve zorg

Management en optimalisatie van hemostase

Antifibrinolytica

Alternatives to allogeneic platelet transfusion. (opent nieuw venster)

Desborough MJ, Smethurst PA, Estcourt LJ, Stanworth SJ.

Bron‎: Br J Haematol 2016;175(3):381-92.

Geïndexeerd‎: PubMed 27650431

DOI‎: 10.1111/bjh.14338

https://www.ncbi.nlm.nih.gov/pubmed/27650431 (opent nieuw venster)

Tranexamic acid in patients undergoing noncardiac surgery. (opent nieuw venster)

Devereaux PJ, Marcucci M, Painter TW, Conen D, Lomivorotov V, Sessler DI, Chan MTV, Borges FK, Martínez-Zapata MJ, Wang CY, Xavier D, Ofori SN, Wang MK, Efremov S, Landoni G, Kleinlugtenbelt YV, Szczeklik W, Schmartz D, Garg AX, Short TG, Wittmann M, Meyhoff CS, Amir M, Torres D, Patel A, Duceppe E, Ruetzler K, Parlow JL, Tandon V, Fleischmann E, Polanczyk CA, Lamy A, Astrakov SV, Rao M, Wu WKK, Bhatt K, de Nadal M, Likhvantsev VV, Paniagua P, Aguado HJ, Whitlock RP, McGillion MH, Prystajecky M, Vincent J, Eikelboom J, Copland I, Balasubramanian K, Turan A, Bangdiwala SI, Stillo D, Gross PL, Cafaro T, Alfonsi P, Roshanov PS, Belley-Côté EP, Spence J, Richards T, VanHelder T, McIntyre W, Guyatt G, Yusuf S, Leslie K; POISE-3 Investigators

Bron‎: N Engl J Med. 2022;386(21):1986-97.

Geïndexeerd‎: PubMed 35363452

DOI‎: 10.1056/NEJMoa2201171

https://pubmed.ncbi.nlm.nih.gov/35363452/ (opent nieuw venster)

Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. (opent nieuw venster)

Henry DA, Carless PA, Moxey AJ, O'Connell D, Stokes BJ, Fergusson DA, Ker K.

Bron‎: Cochrane Database Syst Rev 2011;(3):CD001886.

Geïndexeerd‎: PubMed 21412876

DOI‎: 10.1002/14651858.CD001886.pub4

https://www.ncbi.nlm.nih.gov/pubmed/21412876 (opent nieuw venster)

Putting the record straight on aprotinin as safe and effective: results from a mixed treatment meta-analysis of trials of aprotinin. (opent nieuw venster)

Howell N, Senanayake E, Freemantle N, Pagano D.

Bron‎: J Thorac Cardiovasc Surg 2013;145(1):234-40.

Geïndexeerd‎: PubMed 22889481

DOI‎: 10.1016/j.jtcvs.2012.07.018

https://www.ncbi.nlm.nih.gov/pubmed/22889481 (opent nieuw venster)

Association of intravenous tranexamic acid with thromboembolic events and mortality: a systematic review, meta-analysis, and meta-regression. (opent nieuw venster)

Taeuber I, Weibel S, Herrmann E, Neef V, Schlesinger T, Kranke P, Messroghli L, Zacharowski K, Choorapoikayil S, Meybohm P

Bron‎: JAMA Surg 2021;156(6):e210884.

Geïndexeerd‎: PubMed 33851983

DOI‎: 10.1001/jamasurg.2021.0884

https://www.ncbi.nlm.nih.gov/pubmed/33851983 (opent nieuw venster)

Oral is as effective as intravenous tranexamic acid at reducing blood loss in thoracolumbar spinal fusions: a prospective randomized trial. (opent nieuw venster)

Yu CC, Fidai M, Washington T, Bartol S, Graziano G

Bron‎: Spine 2022;47(2):91-8.

Geïndexeerd‎: PubMed 34224510

DOI‎: 10.1097/BRS.0000000000004157

https://pubmed.ncbi.nlm.nih.gov/34224510/ (opent nieuw venster)

Recombinante geactiveerde factor VII (rFVIIa)

The treatment of bleeding is to stop the bleeding! Treatment of trauma-related hemorrhage. (opent nieuw venster)

Boffard KD, Choong PI, Kluger Y, Riou B, Rizoli SB, Rossaint R, Warren B; NovoSeven Trauma Study Group.

Bron‎: Transfusion 2009;49 Suppl 5:240S-7S.

Geïndexeerd‎: PubMed 19954486

DOI‎: 10.1111/j.1537-2995.2008.01987.x

https://www.ncbi.nlm.nih.gov/pubmed/19954486 (opent nieuw venster)

Comprehensive Canadian review of the off-label use of recombinant activated factor VII in cardiac surgery. (opent nieuw venster)

Karkouti K, Beattie WS, Arellano R, Aye T, Bussieres JS, Callum JL, Cheng D, Heinrich L, Kent B, Lee TW, MacAdams C, Mazer CD, Muirhead B, Rochon AG, Rubens FD, Sawchuk C, Wang S, Waters T, Wong BI, Yau TM.

Bron‎: Circulation 2008;118(4):331-8.

Geïndexeerd‎: PubMed 18606914

DOI‎: 10.1161/CIRCULATIONAHA.108.764308

https://www.ncbi.nlm.nih.gov/pubmed/18606914 (opent nieuw venster)

Recombinant factor VIIa as last-resort treatment of desperate haemorrhage. (opent nieuw venster)

Palmason R, Vidarsson B, Sigvaldason K, Ingimarsson JP, Gudbjartsson T, Sigurdsson GH, Onundarson PT.

Bron‎: Acta Anaesthesiol Scand 2012;56(5):636-44.

Geïndexeerd‎: PubMed 22489992

DOI‎: 10.1111/j.1399-6576.2012.02688.x

https://www.ncbi.nlm.nih.gov/pubmed/22489992 (opent nieuw venster)

Coagulatiefactorconcentraten

Prophylactic use of factor IX concentrate in a Jehovah's Witness patient. (opent nieuw venster)

Bolliger D, Sreeram G, Duncan A, Molinaro RJ, Szlam F, Chen EP, Tanaka KA.

Bron‎: Ann Thorac Surg 2009;88(5):1666-8.

Geïndexeerd‎: PubMed 19853132

DOI‎: 10.1016/j.athoracsur.2009.03.095

https://www.ncbi.nlm.nih.gov/pubmed/19853132 (opent nieuw venster)

Bloodless orthotopic heart transplantation in a Jehovah's Witness. (opent nieuw venster)

Dallas T, Welsby I, Bottiger B, Milano C, Daneshmand M, Guinn N.

Bron‎: A A Case Rep 2015;4(10):140-2.

Geïndexeerd‎: PubMed 25974419

DOI‎: 10.1213/XAA.0000000000000067

https://www.ncbi.nlm.nih.gov/pubmed/25974419 (opent nieuw venster)

Fibrinogen replacement therapy: a critical review of the literature. (opent nieuw venster)

Franchini M, Lippi G.

Bron‎: Blood Transfus 2012;10(1):23-7.

Geïndexeerd‎: PubMed 22153684

DOI‎: 10.2450/2011.0015-11

https://www.ncbi.nlm.nih.gov/pubmed/22153684 (opent nieuw venster)

Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery. A prospective randomised pilot study. (opent nieuw venster)

Karlsson M, Ternström L, Hyllner M, Baghaei F, Flinck A, Skrtic S, Jeppsson A.

Bron‎: Thromb Haemost 2009;102(1):137-44.

Geïndexeerd‎: PubMed 19572078

DOI‎: 10.1160/TH08-09-0587

https://www.ncbi.nlm.nih.gov/pubmed/19572078 (opent nieuw venster)

Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy. (opent nieuw venster)

Levy JH, Welsby I, Goodnough LT.

Bron‎: Transfusion 2014;54(5):1389-405.

Geïndexeerd‎: PubMed 24117955

DOI‎: 10.1111/trf.12431

https://www.ncbi.nlm.nih.gov/pubmed/24117955 (opent nieuw venster)

Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: a randomized, placebo-controlled trial. (opent nieuw venster)

Rahe-Meyer N, Solomon C, Hanke A, Schmidt DS, Knoerzer D, Hochleitner G, Sørensen B, Hagl C, Pichlmaier M.

Bron‎: Anesthesiology 2013;118(1):40-50.

Geïndexeerd‎: PubMed 23249928

DOI‎: 10.1097/ALN.0b013e3182715d4d

https://www.ncbi.nlm.nih.gov/pubmed/23249928 (opent nieuw venster)

Bleeding in a Jehovah's Witness patient undergoing a redo aortic valve replacement controlled with cryoprecipitate and a prothrombin complex concentrate. (opent nieuw venster)

Robblee JA, Wilkes PR, Dickie SJ, Rubens FD, Bormanis J.

Bron‎: Can J Anaesth 2012;59(3):299-303.

Geïndexeerd‎: PubMed 22161243

DOI‎: 10.1007/s12630-011-9647-7

https://www.ncbi.nlm.nih.gov/pubmed/22161243 (opent nieuw venster)

Desmopressine

Effects of desmopressin on platelet function under conditions of hypothermia and acidosis: an in vitro study using multiple electrode aggregometry. (opent nieuw venster)

Hanke AA, Dellweg C, Kienbaum P, Weber CF, Görlinger K, Rahe-Meyer N.

Bron‎: Anaesthesia 2010;65(7):688-91.

Geïndexeerd‎: PubMed 20477783

DOI‎: 10.1111/j.1365-2044.2010.06367.x

https://www.ncbi.nlm.nih.gov/pubmed/20477783 (opent nieuw venster)

Visco-elastische tests ter vaststelling van chirurgische of coagulopathische bloedingen

Management of severe perioperative bleeding: Guidelines from the European Society of Anaesthesiology. (opent nieuw venster)

Kozek-Langenecker SA, Afshari A, Albaladejo P, Santullano CA, De Robertis E, Filipescu DC, Fries D, Görlinger K, Haas T, Imberger G, Jacob M, Lancé M, Llau J, Mallett S, Meier J, Rahe-Meyer N, Samama CM, Smith A, Solomon C, Van der Linden P, Wikkelsø AJ, Wouters P, Wyffels P.

Bron‎: Eur J Anaesthesiol 2013;30(6):270-382.

Geïndexeerd‎: PubMed 23656742

DOI‎: 10.1097/EJA.0b013e32835f4d5b

https://www.ncbi.nlm.nih.gov/pubmed/23656742 (opent nieuw venster)